782 results found
The Australian Government commissioned a review of the clinical effectiveness of 16 natural therapies excluded from private health insurance rebates in April 2019. The Department of Health and Aged Care engaged National Health and Medical Research Council (NHMRC) to assist in its review by commissioning evidence evaluations that assessed published scientific research on the excluded therapies. NHMRC completed its role in the Natural Therapies Review 2024 with submission of all finalised evidence evaluations to the Department of Health and Aged Care in January 2025.
Our commitment to improving the health of Aboriginal and Torres Strait Islander peoples covers all aspects of NHMRC’s responsibilities, as well as contributing to the Australian Government’s National Aboriginal and Torres Strait Islander Health Plan 2021-2031.NHMRC renewed our Innovate Reconciliation Action Plan (RAP) in collaboration with Reconciliation Australia about turning good intentions into real actions and rising to the challenge of reconciling Australia. A RAP is a business plan that uses a holistic approach to create meaningful relationships, enhance respect and promote sustainable opportunities for Aboriginal and Torres Strait Islander Australians.Our previous Reconciliation Action Plan 2016-2018, is available on the National Library's Australian Government Web Archive.
CEO Communique – February 2022
Members of the Council of National Health and Medical Research Council (NHMRC), 2024–2027 triennium.
Linked to Road Map 3: A Strategic Framework for Improving Aboriginal and Torres Strait Islander Health through Research (Road Map 3)
Professor Sandra Eades from Curtin University has dedicated her career to research in Aboriginal health improvements. Professor Eades works with National Health and Medical Research Council (NHMRC) to advise and develop strategic guidelines focused on closing the gap.
NHMRC is committed to building and strengthening the capacity and capability amongst Aboriginal and Torres Strait Islander health researchers. We do this through funding, events and educational opportunities. Read about some of the capacity and capability initiatives we are involved with.
Around 1,786 new cases of ovarian cancer in Australia were estimated to have been diagnosed in 2023, which is the equivalent of a 1 in 87 lifetime risk.In our first Speaking of Science webinar, held for Ovarian Cancer Awareness Month, we were joined by international expert in ovarian cancer research, Professor Susan Ramus (Professor of Molecular Oncology in the School of Clinical Medicine at the University of New South Wales).
NHMRC recognises excellence in the health and medical research sector through its annual Research Excellence Awards. Find our 2023 award winners listed below.
The 45th biannual report
NHMRC recognises excellence in the health and medical research sector through its annual Research Excellence Awards.
The NHMRC Corporate Plan 2025–26 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2025–26 and over the next few years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years.